ClinicalTrials.Veeva

Menu

Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient Elastography

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Enrolling

Conditions

Chronic Liver Injury
Mindray Hepatus 9 Ultrasound Diagnostic System

Treatments

Other: Visual Transient Elastography (ViTE) Examination

Study type

Observational

Funder types

Other

Identifiers

NCT07128108
Hepatus-V1

Details and patient eligibility

About

Using liver biopsy as the gold standard, this study will conduct visual transient elastography (ViTE) examinations using Mindray Hepatus 9 ultrasound diagnostic system in patients with liver injury to evaluate the diagnostic efficacy of Liver Steatosis Analysis (LiSA) and ViTE for grading hepatic steatosis and fibrosis, and establish corresponding diagnostic thresholds.

Enrollment

225 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Be aged 18-65 years.
  • Documented liver injury of any etiology with a liver biopsy performed within the past 2 weeks.
  • Willing to undergo Visual Transient Elastography (ViTE) examination using Mindray Hepatus 9 Ultrasound System and capable of providing written informed consent.

Exclusion criteria

  • Acute viral hepatitis.
  • Right heart failure with either:Serum transaminases >5× upper limit of normal (ULN),Total bilirubin >85.5 μmol/L.
  • History of hepatocellular carcinoma (HCC).
  • Pregnancy.
  • Patients with implantable medical devices.

Trial contacts and locations

1

Loading...

Central trial contact

Chao Sun, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems